Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective

Stefanini GG., 2013, Drug-eluting coronary-artery stents., N Engl J Med., 368, 254, 10.1056/NEJMra1210816

Iqbal J., 2014, Bioresorbable scaffolds: rationale, current status, challenges, and future., Eur Heart J., 35, 765, 10.1093/eurheartj/eht542

Serruys PW., 2014 Sep 12, A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial., Lancet., Epub AOP

Capodanno D., 2014 Jul 18., Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry., EuroIntervention., Epub AOP

Abizaid A., 2014 Apr 29., The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled., EuroIntervention., Epub AOP

Ishibashi Y., 2014 Sep 22, Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients., EuroIntervention., Epub AOP

Gori T., 2014, Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds., JACC Cardiovasc Interv., 7, 1194, 10.1016/j.jcin.2014.07.004

Ormiston JA., 2014 May 20, Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies., EuroIntervention., Epub AOP

Morino Y., 2008, Functional formula to determine adequate balloon diameter of simultaneous kissing balloon technique for treatment of bifurcated coronary lesions: clinical validation by volumetric intravascular ultrasound analysis., Circ J., 72, 886, 10.1253/circj.72.886

Farooq V., 2013, Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice., JACC Cardiovasc Interv., 6, 523, 10.1016/j.jcin.2012.12.131

Gori T., 2014, Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes., EuroIntervention., 9, 1036, 10.4244/EIJV9I9A176

Diletti R., 2014, Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study., Eur Heart J., 35, 777, 10.1093/eurheartj/eht546

Kocka V., 2014, Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study ‘Prague 19’., Eur Heart J., 35, 787, 10.1093/eurheartj/eht545

Valenti R., 2013, Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion., J Am Coll Cardiol., 61, 545, 10.1016/j.jacc.2012.10.036

Morino Y., 2011, Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO score as a difficulty grading and time assessment tool., JACC Cardiovasc Interv., 4, 213, 10.1016/j.jcin.2010.09.024

Gomez-Lara J., 2011, Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography., JACC Cardiovasc Interv., 4, 992, 10.1016/j.jcin.2011.03.020

Brown AJ., 2014, Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation., Catheter Cardiovasc Interv., 84, 37, 10.1002/ccd.25378

Nakatani S., 2014 Feb 27., Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial., EuroIntervention., Epub AOP

Tada T., 2012, Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining., Circ Cardiovasc Interv., 5, 649, 10.1161/CIRCINTERVENTIONS.112.968487

Kraak RP., 2014 Aug 20, Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry., EuroIntervention., Epub AOP

Fernández-Rodríguez D., 2014, Acute Absorb bioresorbable vascular scaffold thrombosis in ST-segment elevation myocardial infarction: to stent or not to stent?, EuroIntervention., 10, 600, 10.4244/EIJV10I5A103

Gomez-Lara J., 2012, Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study., EuroIntervention., 8, 214, 10.4244/EIJV8I2A35

Otsuka F., 2014, Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model., Circ Cardiovasc Interv., 7, 330, 10.1161/CIRCINTERVENTIONS.113.000990

Farooq V., 2012, Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: a sub-study of the ABSORB Cohort B and the on-going ABSORB EXTEND Single Arm Study., Catheter Cardiovasc Interv., 79, 880, 10.1002/ccd.23177

Konstantinides SV., 2014, 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism., Eur Heart J., 35, 3033, 10.1093/eurheartj/ehu243

King SB 3rd., 2008, 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines., J Am Coll Cardiol., 51, 172, 10.1016/j.jacc.2007.10.002

Gogas BD., 2012, Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial., JACC Cardiovasc Interv., 5, 656, 10.1016/j.jcin.2012.02.017

Farooq V., 2011, Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application., EuroIntervention., 7, 386, 10.4244/EIJV7I3A64

Onuma Y., 2011, Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?, Circulation., 123, 779, 10.1161/CIRCULATIONAHA.110.971606

Ishibashi Y., 2014, Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial., EuroIntervention., 10, 449, 10.4244/EIJV10I4A78

Onuma Y., 2013, Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial., JACC Cardiovasc Interv., 6, 999, 10.1016/j.jcin.2013.05.017

Serruys PW., 2009, A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods., Lancet., 373, 897, 10.1016/S0140-6736(09)60325-1

Ielasi A., 2014 Oct 30, Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre “Registro ABSORB Italiano” (RAI registry)., EuroIntervention., Epub AOP

Wöhrle J., 2014 Dec 16, Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds., EuroIntervention., Epub AOP

Kocka V., 2013, ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases., Eur Heart J., 34, 2073, 10.1093/eurheartj/eht168